U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Moorin Jay (0001033508)
| State of Inc.: NJ | Fiscal Year End: 1231
Mailing Address
C/O PROQUEST INVESTMENTS, L.P
2430 VANDERBILT BEACH ROAD, #108 - 190
NAPLES FL 34109
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
UroGen Pharma Ltd. 0001668243 2017-05-09 10 percent owner
Arno Therapeutics, Inc 0001195116 2016-01-12 director
EAGLE PHARMACEUTICALS, INC. 0000827871 2015-05-06 director, 10 percent owner
Immune Design Corp. 0001437786 2015-03-05 10 percent owner
AGILE THERAPEUTICS INC 0001261249 2014-05-22 10 percent owner
MAPLE MOUNTAIN EXPLORATIONS INC.
Current Name:Pegasi Energy Resources Corporation.		 0001363254 2014-01-31 director
ACHILLION PHARMACEUTICALS INC 0001070336 2008-08-12 10 percent owner
AVANIR PHARMACEUTICALS
Current Name:AVANIR PHARMACEUTICALS, INC.		 0000858803 2008-08-05 10 percent owner
CADENCE PHARMACEUTICALS INC 0001333248 2006-10-30 10 percent owner
Paratek Pharmaceuticals, Inc. 0001178711 2006-05-03 director
PALATIN TECHNOLOGIES INC 0000911216 2005-11-29 10 percent owner
NOVADEL PHARMA INC 0001043873 2005-05-26 10 percent owner
THRESHOLD PHARMACEUTICALS INC
Current Name:Molecular Templates, Inc.		 0001183765 2005-02-04 10 percent owner
PHARMION CORP 0001203866 2003-11-05 director
CYPRESS BIOSCIENCE INC 0000716054 2003-10-14 10 percent owner


Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2016-01-27   AGILE THERAPEUTICS INC 4 P-Purchase --I 393700.0000 5062363.0000 1 0001261249 Common Stock
A 2016-01-12   Arno Therapeutics, Inc 4 A-Award --D 88648.0000 88648.0000 2 0001195116 Stock Option (right to buy)
A 2016-01-04   EAGLE PHARMACEUTICALS, INC. 4 A-Award --D 15000.0000 15000.0000 1 0000827871 Stock Option (right to buy)
A 2015-04-21   EAGLE PHARMACEUTICALS, INC. 4 A-Award --D 10000.0000 10000.0000 1 0000827871 Stock Option (right to buy)
A 2015-03-13   EAGLE PHARMACEUTICALS, INC. 4 A-Award --D 5000.0000 5000.0000 1 0000827871 Option (right to buy)
A 2015-01-23   AGILE THERAPEUTICS INC 4 P-Purchase --I 811966.0000 4668663.0000 1 0001261249 Common Stock
A 2015-01-09   Pegasi Energy Resources Corporation. 4 P-Purchase --D 694444.0000 694444.0000 2 0001363254 Warrants
A 2015-01-09   Pegasi Energy Resources Corporation. 4 P-Purchase --D 250000.0000 250000.0000 1 0001363254 Convertible Note
D 2014-05-29   AGILE THERAPEUTICS INC 4 C-Conversion --I $0.0000 10 0001261249 Convertible Subordinated Notes
D 2014-05-29   AGILE THERAPEUTICS INC 4 J-Other --I 141825.0000 0.0000 9 0001261249 Warrants (right to buy)
D 2014-05-29   AGILE THERAPEUTICS INC 4 C-Conversion --I 328821.0000 0.0000 8 0001261249 Series C Preferred Stock
D 2014-05-29   AGILE THERAPEUTICS INC 4 C-Conversion --I 1393000.0000 0.0000 7 0001261249 Series B Preferred Stock
D 2014-05-29   AGILE THERAPEUTICS INC 4 C-Conversion --I 117441.0000 0.0000 6 0001261249 Series A-1 Preferred Stock
A 2014-05-29   AGILE THERAPEUTICS INC 4 P-Purchase --I 1120833.0000 3856697.0000 5 0001261249 Common Stock
A 2014-05-29   AGILE THERAPEUTICS INC 4 C-Conversion --I 158174.0000 2735864.0000 4 0001261249 Common Stock
A 2014-05-29   AGILE THERAPEUTICS INC 4 C-Conversion --I 460350.0000 2577690.0000 3 0001261249 Common Stock
A 2014-05-29   AGILE THERAPEUTICS INC 4 C-Conversion --I 1950200.0000 2117340.0000 2 0001261249 Common Stock
A 2014-05-29   AGILE THERAPEUTICS INC 4 C-Conversion --I 164417.0000 167140.0000 1 0001261249 Common Stock
A 2014-04-08   EAGLE PHARMACEUTICALS, INC. 4 A-Award --D 4680.0000 4680.0000 1 0000827871 Stock Option (right to buy)
A 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 X-InTheMoney --I 21837.0000 4437495.0000 5 0000827871 Common Stock, $0.001 par value
A 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 C-Conversion --I 1927986.0000 1966987.0000 1 0000827871 Common Stock, $0.001 par value
A 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 C-Conversion --I 1028613.0000 2995600.0000 2 0000827871 Common Stock, $0.001 par value
A 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 C-Conversion --I 850520.0000 3846120.0000 3 0000827871 Common Stock, $0.001 par value
A 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 C-Conversion --I 569538.0000 4415658.0000 4 0000827871 Common Stock, $0.001 par value
A 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 P-Purchase --I 333333.0000 4770828.0000 6 0000827871 Common Stock, $0.001 par value
A 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 C-Conversion --I 62575.0000 62575.0000 7 0000827871 Common Stock, $0.001 par value
A 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 C-Conversion --I 9359.0000 71934.0000 8 0000827871 Common Stock, $0.001 par value
A 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 X-InTheMoney --I 357.0000 72291.0000 9 0000827871 Common Stock, $0.001 par value
D 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 C-Conversion --I 1927986.0000 0.0000 11 0000827871 Series A Convertible Preferred Stock
D 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 C-Conversion --I 1028613.0000 0.0000 12 0000827871 Series B Convertible Preferred Stock
D 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 C-Conversion --I 850520.0000 0.0000 13 0000827871 Series B-1 Convertible Preferred Stock
D 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 C-Conversion --I 569538.0000 0.0000 14 0000827871 Series C Convertible Preferred Stock
D 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 X-InTheMoney --I 98368.0000 0.0000 15 0000827871 Series C Warrants
D 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 C-Conversion --I 62575.0000 0.0000 16 0000827871 Series B-1 Convertible Preferred Stock
D 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 X-InTheMoney --I 1614.0000 0.0000 18 0000827871 Series C Warrants
D 2014-02-18   EAGLE PHARMACEUTICALS, INC. 4 C-Conversion --I 9359.0000 0.0000 17 0000827871 Series C Convertible Preferred Stock
A 2011-04-04   NOVADEL PHARMA INC 4 J-Other --I 14696117.0000 17120360.0000 6 0001043873 Series A Warrants to Purchase Common Stock
A 2010-11-10   NOVADEL PHARMA INC 4 X-InTheMoney --I 297571.0000 34650709.0000 1 0001043873 Common Stock
D 2010-11-10   NOVADEL PHARMA INC 4 X-InTheMoney --I 1394871.0000 0.0000 2 0001043873 Warrants to Purchase Common Stock
A 2010-03-31   NOVADEL PHARMA INC 4 P-Purchase --I 4848485.0000 34353138.0000 1 0001043873 Common Stock
A 2010-03-31   NOVADEL PHARMA INC 4 P-Purchase --I 2424243.0000 2424243.0000 7 0001043873 Series A Warrants to Purchase Common Stock
A 2010-03-31   NOVADEL PHARMA INC 4 P-Purchase --I 1616162.0000 1616162.0000 8 0001043873 Series B Warrants to Purchase Common Stock
A 2009-12-31   NOVADEL PHARMA INC 4 C-Conversion --I 23237083.0000 29504653.0000 1 0001043873 Common Stock
D 2009-12-31   NOVADEL PHARMA INC 4 C-Conversion --I 220726.0000 1394871.0000 2 0001043873 Warrants to Purchase Common Stock
D 2009-12-31   NOVADEL PHARMA INC 4 C-Conversion --I 2069074.0000 0.0000 5 0001043873 10% Secured Convertible Notes
D 2009-12-31   NOVADEL PHARMA INC 4 C-Conversion --I 10744681.0000 0.0000 7 0001043873 10% Secured Convertible Notes
D 2009-12-17   ACHILLION PHARMACEUTICALS INC 4 S-Sale --I 70000.0000 2663854.0000 2 0001070336 Common Stock
D 2009-12-16   ACHILLION PHARMACEUTICALS INC 4 S-Sale --I 493452.0000 2733854.0000 1 0001070336 Common Stock
D 2009-10-13   AVANIR PHARMACEUTICALS, INC. 4 S-Sale --I 547135.0000 7125754.0000 3 0000858803 Class A Common Stock
D 2009-10-12   AVANIR PHARMACEUTICALS, INC. 4 S-Sale --I 427145.0000 7672889.0000 2 0000858803 Class A Common Stock
D 2009-10-09   AVANIR PHARMACEUTICALS, INC. 4 S-Sale --I 804712.0000 8100034.0000 1 0000858803 Class A Common Stock
D 2009-08-11   AVANIR PHARMACEUTICALS, INC. 4 S-Sale --I 894120.0000 8904746.0000 1 0000858803 Class A Common Stock
D 2009-04-29   NOVADEL PHARMA INC 4 J-Other --I 2930926.0000 2069074.0000 5 0001043873 10% Secured Convertible Notes
D 2009-04-29   NOVADEL PHARMA INC 4/A J-Other --I 3389831.0000 1610169.0000 1 0001043873 10% Secured Convertible Notes
A 2008-10-22   AVANIR PHARMACEUTICALS 4 P-Purchase --I 10600.0000 9798866.0000 1 0000858803 Class A Common Stock
A 2008-10-17   NOVADEL PHARMA INC 4 P-Purchase --I 6446809.0000 6446809.0000 8 0001043873 Warrants to Purchase Common Stock
A 2008-10-17   NOVADEL PHARMA INC 4 P-Purchase --I 10744681.0000 10744681.0000 7 0001043873 10% Secured Convertible Notes
A 2008-10-15   AVANIR PHARMACEUTICALS 4 P-Purchase --I 6465.0000 9788266.0000 3 0000858803 Class A Common Stock
A 2008-10-14   AVANIR PHARMACEUTICALS 4 P-Purchase --I 32300.0000 9781801.0000 2 0000858803 Class A Common Stock
A 2008-10-10   AVANIR PHARMACEUTICALS 4 P-Purchase --I 73551.0000 9749501.0000 1 0000858803 Class A Common Stock
A 2008-10-09   AVANIR PHARMACEUTICALS 4 P-Purchase --I 41385.0000 9675950.0000 3 0000858803 Class A Common Stock
A 2008-10-08   AVANIR PHARMACEUTICALS 4 P-Purchase --I 114384.0000 9634565.0000 2 0000858803 Class A Common Stock
A 2008-10-07   AVANIR PHARMACEUTICALS 4 P-Purchase --I 21318.0000 9520181.0000 1 0000858803 Class A Common Stock
A 2008-09-17   AVANIR PHARMACEUTICALS 4 P-Purchase --I 413217.0000 9498863.0000 3 0000858803 Class A Common Stock
A 2008-09-16   AVANIR PHARMACEUTICALS 4 P-Purchase --I 17387.0000 9085646.0000 2 0000858803 Class A Common Stock
A 2008-09-15   AVANIR PHARMACEUTICALS 4 P-Purchase --I 244449.0000 9068259.0000 1 0000858803 Class A Common Stock
A 2008-09-10   AVANIR PHARMACEUTICALS 4 P-Purchase --I 48103.0000 8823810.0000 3 0000858803 Class A Common Stock
A 2008-09-09   AVANIR PHARMACEUTICALS 4 P-Purchase --I 146400.0000 8775707.0000 2 0000858803 Class A Common Stock
A 2008-09-08   AVANIR PHARMACEUTICALS 4 P-Purchase --I 125000.0000 8629307.0000 1 0000858803 Class A Common Stock
A 2008-09-04   AVANIR PHARMACEUTICALS 4 P-Purchase --I 52113.0000 8504307.0000 3 0000858803 Class A Common Stock
A 2008-09-03   AVANIR PHARMACEUTICALS 4 P-Purchase --I 6864.0000 8452194.0000 2 0000858803 Class A Common Stock
A 2008-09-02   AVANIR PHARMACEUTICALS 4 P-Purchase --I 323550.0000 8445330.0000 1 0000858803 Class A Common Stock
A 2008-08-27   AVANIR PHARMACEUTICALS 4 P-Purchase --I 89447.0000 8121780.0000 1 0000858803 Class A Common Stock
A 2008-08-15   AVANIR PHARMACEUTICALS 4 P-Purchase --I 114032.0000 8032333.0000 2 0000858803 Class A Common Stock
A 2008-08-14   AVANIR PHARMACEUTICALS 4 P-Purchase --I 6051.0000 7918301.0000 1 0000858803 Class A Common Stock
A 2008-08-07   AVANIR PHARMACEUTICALS 4 P-Purchase --I 91380.0000 7912250.0000 2 0000858803 Class A Common Stock
A 2008-08-06   AVANIR PHARMACEUTICALS 4 P-Purchase --I 400.0000 7820870.0000 1 0000858803 Class A Common Stock
A 2008-05-30   NOVADEL PHARMA INC 4 P-Purchase --I 5000000.0000 5000000.0000 5 0001043873 10% Secured Convertible Notes
A 2008-05-30   NOVADEL PHARMA INC 4 P-Purchase --I 3000000.0000 3000000.0000 6 0001043873 Warrants to Purchase Common Stock
A 2007-01-17   NOVACEA INC 4 A-Award --D 12500.0000 12500.0000 2 0001178711 Stock Option (right to buy)

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016